Legacy Education Raises Revenue 24.8% to $80.1 Million in Fiscal 2026
Key Facts
Legacy Education reported that revenue rose 24.8% to $80.1 million in fiscal 2026, according to the company’s investor statement on results for the year ended. Chief Executive LeeAnn Rohmann said revenue, new student starts and year-end student enrollment increased. She attributed the gains to "continued demand for career education programs." Annual results also included increases in net income and diluted earnings per share, alongside reported levels of operating earnings. The company also said revenue growth was affected by the comparison of the Contra Costa Medical Career College acquisition period with the prior year.
Net income was $9.1 million in fiscal 2026, up 21.3% from the prior year, according to the company. Diluted earnings per share rose 11.9% to $0.66. EBITDA was about $12.5 million, and adjusted EBITDA was $13.6 million. These figures put annual revenue growth alongside improvements in earnings and net income, while the available facts did not provide quarterly comparisons for these measures. Rohmann said the increases included revenue, student enrollment starts and year-end enrollment, without attributing each measure to a separate factor.
The company said 3,483 new student starts drove revenue in fiscal 2026, and enrolled students increased 9% to 3,377. It also said the timing of the December 2024 acquisition of Contra Costa Medical Career College affected the year-over-year comparison. Fiscal 2026 included a full year of revenue from the college, compared with half a year in the prior period. That means the revenue comparison combined business growth with the effect of a different period of inclusion for the college’s revenue. The available facts did not break out how much each factor contributed to the reported increase.
On geographic expansion, Legacy Education said it signed a lease for its first planned campus in Houston, Texas, in a move it said would expand its reach beyond California. It also said the launch of two new degree programs and one certificate program at Contra Costa Medical Career College was planned for the second quarter of fiscal 2027. The plans link expansion to a new location with the addition of educational programs at the college whose revenue was included in the annual comparison. The available facts did not include an update on the campus opening or program launches after the planned schedule.
In trading on November 11, 2026, LGCY shares closed at $8.6, according to EL7 data. The available facts do not include the share’s movement in other sessions or its trading range that day. The close also came after the fiscal 2026 year covered by the company’s results and does not by itself establish a market reaction to results for a later quarter. The company’s announcement that the launches were planned for the second quarter of fiscal 2027 was the latest specified timing in the available information on its new programs.